1. Introduction
===============

Insulin dependent diabetes mellitus (IDDM), also known as type 1 diabetes, is a heterogeneous disease caused by polygene inheritance and associated with autoimmune disorders.^\[[@R1],[@R2]\]^ In recent years, it has been found that some genes of MHC II region (*DR3*, *DQA1*, and *DQB1*) are susceptible factors for IDDM.^\[[@R3],[@R4]\]^ However, these could not explain all of the genetic features of IDDM. Many researchers are still looking for new genes associated with the development of IDDM. The majority protease (large multifunctional protease, LMP) gene located in the region of (MHC) II and was a major histocompatibility complex in human beings. *LMP* genes including *LMP2* and *LMP7*, are polymorphic and their products constitute 2 subunits of the proteosome complex involved in the degradation of cytosolic proteins and generation of antigenic peptides.^\[[@R5]--[@R7]\]^

There were no consistent results in the publications of the genetic association between *LMP* gene polymorphisms and IDDM. Deng et al^\[[@R8]\]^ found that *LMP2* is a susceptibility gene for type 1 diabetes, but only in *DR4-DQB1*∗ 0302 haplotypes. And the association between the *LMP* gene and type 1 diabetes is shown to be secondary to the linkage imbalance between the gene and *HLA-DR/DQ*.^\[[@R9]\]^ Ding et al^\[[@R10]\]^ has indicated that *LMP2-R/H* genotype may be an independent protective factor for type 1 diabetes mellitus in South China. However, no association between *LMP2* and IDDM has been observed in other ethnic groups.^\[[@R11],[@R12]\]^ These results suggested that the association between the polymorphism of the *LMP2* gene and IDDM needs to be further strengthened. In addition, significantly increased risk was detected between *LMP7* polymorphism and IDDM independent of the *HLA-DRB1-DQ* haplotypes.^\[[@R8]\]^ Furthermore, a study in Norwegian population has indicated that stratification of data according to *HLA-DRB1∗04* subtypes was important when considered the role of *LMP7*.^\[[@R11]\]^

Given the controversy role of *LMP2* and *LMP7* in genetic susceptibility to IDDM, the aim of this study was to determine whether polymorphisms of *LMP2* and *LMP7* were associated with IDDM by using a meta-analysis.

2. Materials and methods
========================

2.1. Patient and public involvement
-----------------------------------

No patient and public involvement and ethical approval is necessary for the present meta-analysis.

2.2. Search strategy
--------------------

A comprehensive search examining the association between the *LMP2* and *LMP7* polymorphisms with IDDM was conducted through the electronic databases including PubMed, Embase, and Chinese National Knowledge Infrastructure (CNKI) using the following terms: "Large multifunctional protease 2" or "*LMP2*" and "Large multifunctional protease 7" or "*LMP7*" and "polymorphism" or "variation" or "single nucleotide polymorphisms" or "SNP" and "insulin dependent diabetes mellitus" or "IDDM" or "Type I diabetes." No language and publication year were restricted. Meanwhile, other potentially relevant literature was identified by searching cross-references within available studies.

2.3. Inclusion and exclusion criteria
-------------------------------------

Inclusion criteria: studies were case-control designed; studies that documented to the association between *LMP2* or *LMP7* polymorphism and IDDM risk; studies contained available genotypes for the calculation of odds ratios (ORs) and 95% confidence intervals (CIs); the distributions of genotypes in controls were in Hardy--Weinberg equilibrium (HWE).

Exclusion criteria: duplicated studies, letters, reviews, case reports, or abstracts; raw data of *LMP2* and *LMP7* genotypes were not available; the distributions of genotypes in controls were not in HWE.

2.4. Data extraction and quality assessment
-------------------------------------------

Two independent authors (GL and YZ) selected the relevant articles according to the inclusion and exclusion criteria and performed the data extraction process. The following information from each study were extracted: the first author, publication year, ethnicity, age, sex, genotype-methods, the number of cases and controls, evidence of HWE in controls. All the data were summarized in Table [1](#T1){ref-type="table"}. All discrepancies were resolved by discussion. The Newcastle-Ottawa Scale (NOS) was used to evaluate the study quality.^\[[@R13]\]^ Total score ranged from 0 (lowest quality) to 8 (highest quality). A study with a score of ≥6 was classified as high quality and recruited in the further analysis.

###### 

The characters of included studies.
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2.5. Statistical analysis
-------------------------

The association between the allelic, dominant, and recessive models of *LMP2* and *LMP7* polymorphisms and IDDM risk was evaluated by pooled OR and 95% CI. The significance of the pooled OR was assessed by the *Z* test. Heterogeneity was evaluated by the *Q*-statistics (significant at *P* \< .05) and *I*^2^ statistics (where \>50% indicates significant heterogeneity). The pooled OR estimate of each study was calculated by the fixed-effect model when there was lack of heterogeneity. Otherwise, the random-effect model was used. Subgroup analysis stratified by ethnicity was also performed in this meta-analysis. The stability of the results was assessed using sensitivity analysis by omitting single study each time to evaluate the influence of each study on the pooled OR. The funnel plot was used to assess potential publication bias. Egger test and Begg tests were performed to evaluate potential publication bias of the literatures. A *P* \< .05 was considered significant. Statistical analyses were performed with the STATA 12.0 (StataCorp, College Station, TX) and Revman 5 (Cochrane Collaboration, London, UK) software.

3. Results
==========

3.1. Selection of eligible study
--------------------------------

The study selection process is shown in Fig. [1](#F1){ref-type="fig"}. A total of 939 publications (612 for *LMP2* and 327 for *LMP7*) were initially retrieved from electronic databases including PubMed, Embase, and CNKI. After reviewing the titles, abstracts, and full text, 716 were excluded for duplicated studies (478 for *LMP2* and 238 for *LMP7*). One hundred eighty nine were excluded for irrelevant studies (118 for *LMP2* and 71 for *LMP7*). Twenty four were excluded for not related to the association between *LMP2* or *LMP7* polymorphisms and IDDM risk (9 for *LMP2* and 18 for *LMP7*). Finally, 7 articles published with 707 cases and 821 controls were included in the current meta-analysis.^\[[@R8]--[@R12],[@R14],[@R15]\]^ The main characteristics of all eligible studies are shown in Table [1](#T1){ref-type="table"}. Among the studies, 4 were conducted in Caucasian population, 2 were in Chinese Han population, and 1 was in African population. Furthermore, 7 studies with 707 cases and 821 controls documented to the association between *LMP2* polymorphism and IDDM risk. And 3 studies with 450 cases and 495 controls documented to the association between *LMP7* polymorphism and IDDM risk.

![Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart of studies inclusion and exclusion.](medi-99-e19482-g002){#F1}

3.2. Association between LMP2 CfoI and IDDM
-------------------------------------------

The results of this meta-analysis are shown in Table [2](#T2){ref-type="table"}. The pooled risk estimates indicated that all the genetic models (allelic, dominant, and recessive models) of *LMP2 CfoI* were not significantly associated with the susceptibility of IDDM (*P* \> .05). Subgroup analysis stratified by ethnicity showed that the significant association between the dominant model of *LMP2 CfoI* and IDDM was detected in Asian population (OR = 1.96, 95% CI: 1.24--3.10, *P* = .004) (Fig. [2](#F2){ref-type="fig"}).

###### 

The association between LMP2 CfoI and LMP7 G37360T polymorphisms and insulin dependent diabetes mellitus.
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![Forest plots of odds ratios for the association between *LMP2* CfoI polymorphism and insulin dependent diabetes mellitus. A = Allelic model; B = Dominant model; C = Recessive model.](medi-99-e19482-g004){#F2}

3.3. Association between LMP7 G37360T and IDDM
----------------------------------------------

For *LMP7* G37360T, subjects with T allele and dominant model had a significantly decreased model: (OR = 0.69, 95% CI: 0.57--0.83, *P* = .0001; dominant model: OR = 0.70, 95% CI: 0.53--0.94, *P* = .02). No association was found between the recessive model of *LMP7* G37360T and IDDM risk (*P* \> .05). In subgroup analyses based on ethnicity, we found that the allelic and dominant models of *LMP7* G37360T were associated with a decreased risk of IDDM in Caucasian population (allelic model: OR = 0.69, 95% CI: 0.56--0.85, *P* = .0005; dominant model: OR = 0.67, 95% CI: 0.50--0.89, *P* = .007), but not in Asian population (*P* \> .05) (Fig. [3](#F3){ref-type="fig"}).
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3.4. Heterogeneity
------------------

Heterogeneity was found for the dominant model of *LMP2 CfoI* and IDDM (*P* = .02, *I*^2^ = 60). Therefore, subgroup analysis was carried out based on ethnicity. Significant heterogeneity remained in the dominant model of *LMP2 CfoI* and IDDM in Caucasian population, but not in Asian population (Table [2](#T2){ref-type="table"}). The significant heterogeneity in these genetic models were contributed mainly by Van Endert et al.^\[[@R12]\]^ Removal of this study from meta-analysis gave 20% heterogeneity (*P* \> .05). In addition, significant heterogeneity was also found for the recessive model of *LMP7* G37360T and IDDM. The heterogeneity remained in Caucasian subgroup analysis (Table [2](#T2){ref-type="table"}). The significant heterogeneity in this genetic model was contributed mainly by Undlien et al.^\[[@R11]\]^ Removal of this study from meta-analysis gave 0% heterogeneity (*P* \> .05).

3.5. Sensitive analysis and publication bias
--------------------------------------------

The sensitivity analysis showed that no single study altered the pooled ORs qualitatively, which provided the evidence of the stability of the meta-analysis (Fig. [4](#F4){ref-type="fig"}). Publication bias was assessed by Begg test and Egger test. As shown in Fig. [5](#F5){ref-type="fig"}, no evidence of publication bias was found.
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4. Discussion
=============

The products encoded by *LMP2* gene are mostly functional protease, which are responsible for processing antigens and participating in the initiation of immune responses (including autoimmune reactions).^\[[@R16],[@R17]\]^ Therefore, we speculate that the *LMP2* gene may be associated with autoimmune diseases. In recent years, the relationship between *LMP2* gene and IDDM has been studied abroad, however, no consistent conclusion has been reached. A recent study by Deng et al^\[[@R8]\]^ suggested that *LMP2-HR* may be the independent protective genotype, and *LMP2-R/H* may be the independent susceptible genotype of IDDM. In addition, Ding et al^\[[@R10]\]^ has detected that the *LMP2-R/H* and *LMP2-R/R* were susceptible to IDDM. However, Undlien et al^\[[@R11]\]^ found that the *LMP2* gene was not a IDDM-independent susceptible gene in Norwegian population. Van Endert et al^\[[@R12]\]^ also analyzed the *LMP2* polymorphism at position 60 in *DR3-DQ2/DR4-DQ8* Danish IDDM patients compared with *HLA-DR* and *-DQ* matched Danish control subjects. Even though the numbers studied were small, those authors found no evidence for an independent association. Kawaguchi et al^\[[@R15]\]^ have studied the same *LMP2* polymorphism in IDDM patients and controls in Japanese, and again found no evidence for an independent association. In the present study, we firstly detected a significant association between the dominant model of *LMP2 CfoI* polymorphism and IDDM risk in Asian population by using a meta-analysis. To confirm this result, further researches with larger number of cases and controls is necessary.

The products encoded by *LMP7* gene are mostly functional protease, which are involved in the processing of antigens to form small molecular peptides.^\[[@R18],[@R19]\]^ Together with the products encoded by *LMP2* and the transporter associated with antigen processing, it is involved in the initiation of immune response. Fehling et al^\[[@R20]\]^ showed that the expression level of MHC I region on the cell surface was significantly decreased, and endogenous antigens could not be presented to lymphocytes effectively, but did not affect the expression of tissue antigen presentation (*TAP*) gene. The addition of exogenous antigenic peptide could restore the expression of MHC I molecule, which proved that the expression product of *LMP7* gene played an important role in the process of antigen presentation.

The relationship between *LMP7* gene and IDDM has been reported in recent years, but the same conclusion has not been reached. Deng et al^\[[@R8]\]^ found that the frequency of *LMP7-A/A* in insulin dependent diabetes mellitus group was significantly higher than that in control group, and the frequency of *LMP7-B/B* in insulin dependent diabetes mellitus group was significantly lower than that in control group, and there was no linkage imbalance between *HLA-DQ/DR* and insulin dependent diabetes mellitus. It is considered that *LMP7-A/A* is an independent susceptible genotype and *LMP7-B/B* is an independent protective genotype. Undlien et al^\[[@R11]\]^ found that the frequency of *LMP7-B/A* was significantly lower than that of the control group. Further *DRB1-DQA1-DQB1* pairing study showed that there was no significant difference in the frequencies of *LMP7* genotypes between IDDM group and control group. In our meta-analysis, we observed that the allelic and dominant models of *LMP7* G37360T were significantly associated with IDDM. Subgroup analysis stratified by ethnicity indicated that these positive associations can only be found in Caucasian population. Furthermore, we also found a significant association between the recessive model of *LMP7* G37360T in Asian population. For there was only 1 study included in Asian subgroup analysis, the result needs to be confirmed by much more studies with larger number of subjects in the future. Notable, the G37360T polymorphism locates at intron 6 of the *LMP7* gene, which does not reveal any amino acid substitutions. The significant association between this polymorphism and IDDM indicate that the G37360T polymorphism might link to polymorphisms affecting the expression of the *LMP7* gene.

Limitations should be taken into account. First, the number of included studies and subjects were relatively small, especially in Asian population. To confirm these results, much more studies with larger number of cases and controls are necessary. Second, ethnic specific effect is an important consideration in meta-analysis. However, there were only 2 different ethnicities in the present study. Larger number of studies with more subjects in multiple ethnicities is needed in the future. Third, the IDDM is caused by multiple factors including genetics and environment, as well as the interaction between the 2 factors. While, we could not assess the influence of environmental factor in the development of IDDM for lack of data.

5. Conclusion
=============

Our combined results suggested an increased risk of the dominant model of *LMP2 CfoI* and a decreased risk of the allelic and dominant models of *LMP7* G37360T in IDDM. To confirm these results, further study with larger sample size and multiple ethnicity is necessary.
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